Last checked at 20 Feb 2019 07:00
Surgical Innovations Group plc
("Surgical Innovations" or "the Company")
Update on contingency planning for no-deal Brexit
Surgical Innovations (AIM: SUN), the designer and manufacturer of innovative technology for minimally invasive surgery, provides an update on contingency planning for the possibility of the U.K. leaving the EU without an appropriate Withdrawal Agreement.
On 15 February 2019, BSI Netherlands confirmed the successful reassignment of all of the Company's product certification from BSI Notified Body 0086 (U.K.) to the Netherlands Notified Body 2797.
Nigel Rogers, Executive Chairman of SI Group, stated: "Amidst speculation in the weekend press of possible disruption to the approvals status of medical devices across the EU following a no-deal Brexit, it is reassuring that we have taken this important precaution. Our first priority is to protect the integrity of our regulatory approvals for the EU market, and this will serve to reassure our distribution partners and end users of continuity in coming months."
For further information contact:
Surgical Innovations Group Plc | www.sigroupplc.com |
Nigel Rogers, Executive Chairman | Tel: +44 (0)113 230 7597 |
Melanie Ross, COO and CFO | |
Walbrook PR (Financial PR & Investor Relations) | Tel: +44 (0)20 7933 8780 or si@walbrookpr.com |
Paul McManus | Mob: +44 (0)7980 541 893 |
Lianne Cawthorne | Mob: +44 (0)7584 391 303 |
N+1 Singer (Nominated Adviser and Broker) | +44 (0)20 7496 3000 |
Richard Lindley | |
Rachel Hayes |